Sana Biotechnology (SANA) is back in focus after Mayo Clinic agreed to collaborate on SC451 for type 1 diabetes and invest up to US$50 million, linking clinical expertise with fresh capital support.

With data as of April 8, 2026, we examine if Anbio Biotechnology(NNNN) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.

In the book, “Priority Technologies,” MIT faculty analyze how the U.S. can move ahead in multiple key industrial sectors — semiconductors, biotechnology, critical minerals, drones, quantum computing, ...

The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...

The Ministry of Science and ICT (MSIT) and the Ministry of Foreign Affairs held the 'Korea-Vietnam Science, Technology and ...

Dr. William A. Haseltine is a distinguished scientist, philanthropist, author, and entrepreneur renowned for his pioneering work in genomics and regenerative medicine. A former Harvard Medical School ...

Wall Street Journal bestselling author, Italian-American singer-songwriter, and gene therapy entrepreneur Patrick Girondi will appear at the Oxford Exchange Book Fair in Tampa on April 23, 2026, from ...

Deploying AI to sift through massive biological datasets to identify patterns humans may not see is helping to spread medical ...

Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the closing of its initial ...

Q1 2026 Earnings Call April 21, 2026 8:00 AM EDTCompany ParticipantsRachel VatnsdalRainer Blair - President, CEO ...

The first time Eshani Surya wrote about her ulcerative colitis was for a writing class assignment at NYU. She began the short ...

Jefferies LLC, Goldman Sachs & Co. LLC, Evercore ISI, and Guggenheim Securities, LLC acted as the joint book-running managers for the offering. LifeSci Capital LLC acted as passive bookrunner for the ...